Oncology Search
Oncology Oncology

Conference Reports

22nd International AIDS Conference (AIDS 2018)
Amsterdam, the Netherlands
23 July 2018 - 27 July 2018
34th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE 2018)
Barcelona, Spain
01 July 2018 - 04 July 2018
23rd Congress of the European Hematology Association (EHA 2018)
Stockholm, Sweden
14 June 2018 - 17 June 2018
American Society of Clinical Oncology (ASCO) 2018 Annual Meeting
Chicago, Illinois
01 June 2018 - 05 June 2018
23rd Hong Kong Medical Forum
05 May 2018 - 06 May 2018
American Association for Cancer Research Annual Meeting (AACR 2018)
Chicago, Illinois, US
14 April 2018 - 18 April 2018
European Lung Cancer Congress (ELCC) 2018
Geneva
11 April 2018 - 14 April 2018
11th European Breast Cancer Conference (EBCC 2018)
Barcelona, Spain
21 March 2018 - 23 March 2018
European Association of Urology (EAU) 2018 Congress
Copenhagen
16 March 2018 - 19 March 2018
2018 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU 2018)
San Francisco, California
08 February 2018 - 10 February 2018
2018 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
San Francisco, California, US
18 January 2018 - 20 January 2018
Hong Kong Society of Uro-Oncology Annual Scientific Meeting 2018
Hong Kong
20 January 2018 - 20 January 2018
59th American Society of Hematology (ASH) Annual Meeting and Exposition
Atlanta, Georgia, US
09 December 2017 - 12 December 2017
2017 San Antonio Breast Cancer Symposium (SABCS)
San Antonio, Texas, US
05 December 2017 - 09 December 2017
ESMO Asia 2017 Congress
Singapore
17 November 2017 - 19 November 2017
2017 Annual Meeting of American Society for Radiation Oncology (ASTRO)
San Diego, California, US
24 September 2017 - 27 September 2017
International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC)
Yokohama, Japan
15 October 2017 - 18 October 2017
European Society for Medical Oncology (ESMO) Congress 2017
Madrid, Spain
08 September 2017 - 12 September 2017
15th Urological Association of Asia Congress (UAA 2017)
04 August 2017 - 06 August 2017
European Society for Medical Oncology (ESMO) 19th World Congress on Gastrointestinal Cancer (WCGC)
Barcelona
28 June 2017 - 01 July 2017
22nd Congress of European Hematology Association (EHA)
Madrid
22 June 2017 - 25 June 2017
American Society of Clinical Oncology (ASCO) 2017 Annual Meeting
Chicago, Illinois, US
02 June 2017 - 06 June 2017
European Lung Cancer Conference (ELCC) 2017
Geneva
05 May 2017 - 08 May 2017
American Society of Clinical Oncology (ASCO) 2017 Genitourinary Cancers Symposium
Orlando, Florida
16 February 2017 - 18 February 2017
7th Association of South-East Asian Pain Societies (ASEAPS) Congress 2017
Yangon
16 February 2017 - 19 February 2017
26th Conference of the Asian Pacific Association for the Study of the Liver (APASL)
Shanghai, China
15 February 2017 - 19 February 2017
2017 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
19 January 2017 - 21 January 2017
European Cancer Congress 2017 (ECCO 2017)
Amsterdam
27 January 2017 - 30 January 2017
European Society for Medical Oncology (ESMO) Asia 2016 Congress
Singapore
16 December 2016 - 19 December 2016
American Society of Hematology (ASH) 58th Annual Meeting
San Diego, California
03 December 2016 - 06 December 2016
2016 San Antonio Breast Cancer Symposium (SABCS)
San Antonio, Texas
06 December 2016 - 10 December 2016
World Conference on Lung Cancer (WCLC) 2016
Vienna
04 December 2016 - 07 December 2016
European Society for Medical Oncology (ESMO) Congress 2016
Copenhagen
07 October 2016 - 11 October 2016
14th Urological Association of Asia Congress (UAA 2016)
Singapore
20 July 2016 - 24 July 2016
European Society for Medical Oncology (ESMO) World Congress of Gastrointestinal Cancer
Barcelona
29 June 2016 - 02 July 2016
21st Congress of Congress of European Hematology Association (EHA)
Copenhagen
09 June 2016 - 12 June 2016
American Society of Clinical Oncology (ASCO) 2016 Annual Meeting
Chicago, IL
03 June 2016 - 08 June 2016
49th Annual Meeting of the European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) 2016
Athens, Greece
25 May 2016 - 28 May 2016
IASLC Asia Pacific Lung Cancer Conference (APLCC) 2016
Chiang Mai
13 May 2016 - 15 May 2016
35th Annual Meeting of the European Society for Radiotherapy and Oncology (ESTRO35)
Turin, Italy
29 April 2016 - 03 May 2016
European Lung Cancer Conference (ELCC) 2016
Geneva
13 April 2016 - 16 April 2016
European Society for Medical Oncology (ESMO) Asia Congress
18 December 2015 - 21 December 2015
American Society of Clinical Oncology (ASCO) 2016 Gastrointestinal Cancers Symposium
San Francisco, CA
21 January 2016 - 23 January 2016
American Society of Clinical Oncology (ASCO) 2016 Genitourinary Cancers Symposium
San Francisco, CA
07 January 2016 - 09 January 2016
2015 San Antonio Breast Cancer Symposium (SABCS)
San Antonio, Texas, US
08 December 2015 - 12 December 2015
57th American Society of Hematology (ASH) Annual Meeting and Exposition
Orlando, Florida, US
05 December 2015 - 08 December 2015
American Society for Radiation Oncology (ASTRO) 57th Annual Meeting
San Antonio, TX
18 October 2015 - 21 October 2015
European Cancer Congress (ECC) 2015
Vienna
25 September 2015 - 29 September 2015
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
A report of the first patient in Malaysia who had successfully completed 16 cycles of brentuximab vedotin
4 days ago
In advanced-stage, newly diagnosed classical, CD30-positive Hodgkin lymphoma (HL), front-line therapy has resulted in durable remission rates in up to 70–90% of patients, although approximately 25–30% of advanced stage HL patients are refractory or relapse following first-line treatment with ABVD (adriamycin, bleomycin, vinblastine, dacarbazine) chemotherapy.1–3 The standard of care for patients with relapsed or refractory (r/r) classical HL is salvage therapy using second-line high-dose chemotherapy (HDCT), followed by autologous haematopoietic stem cell transplant (ASCT) in eligible patients, which can induce a complete remission (CR) in about 50% of patients.4 Nevertheless, the prognosis of patients who relapse after the salvage HDCT/ASCT is exceedingly poor, with a median survival duration of approximately 1.2 years.5
Advent of rapid-onset opioids: a breakthrough in cancer pain management
29 Nov 2017
Rapid onset opioids may allow for more effective treatment of breakthrough cancer pain as their pharmacokinetic profile closely mimics the pain’s time course